Surgical removal of infected or diseased bone tissue from one or more facial bones, typically performed for osteomyelitis or bone abscess that has not responded to antibiotic therapy.
Verified May 8, 2026 · 6 sources ↓
- Medicare
- $576.17
- Total RVUs
- 17.25
- Global, days
- 90
- Region
- Other
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 6 cited references ↓
- Imaging (CT or MRI) confirming osteomyelitis or bone abscess in the specified facial bone(s)
- Operative note identifying the specific facial bone(s) excised by anatomic name (e.g., mandible, maxilla, zygoma)
- Documentation that conservative treatment (antibiotics) was attempted and failed, or that severity required immediate surgical intervention
- Extent of bone removed and description of debridement performed, including any necrotic tissue involvement
- Pathology specimen disposition — whether excised bone was sent for culture and/or histopathology
- Anesthesia type used and justification for operative setting (hospital vs. ASC)
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 6 cited references ↓
CPT 21026 covers open excision of facial bone — most commonly indicated for osteomyelitis or a bone abscess of the mandible, maxilla, or other craniofacial skeleton. The surgeon incises overlying soft tissue, removes the necrotic or infected osseous segment, and debrides surrounding tissue before closure. This is not a superficial soft-tissue procedure; it requires access to cortical or cancellous bone and is typically performed under general anesthesia in a hospital or ASC setting.
The code carries a 90-day global period. All routine postoperative management through day 90 is bundled — including wound checks, suture removal, and minor debridements. Separate E/M visits within that window require modifier 24 (unrelated) or modifier 25 (significant, separately identifiable on the same day as a minor procedure, though 21026 is not a minor procedure). If the patient requires an unplanned return to the OR for a related problem during the global, bill modifier 78. For a wholly unrelated procedure in the global window, use modifier 79.
This code is predominantly billed by oral and maxillofacial surgeons. Orthopedic and ENT coders encounter it occasionally when craniofacial bone involvement accompanies broader infections or trauma sequelae. The site-of-service differential between HOPD and ASC is substantial — verify the patient's surgical setting before finalizing the claim.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 5.56 |
| Practice expense RVU | 10.94 |
| Malpractice RVU | 0.75 |
| Total RVU | 17.25 |
| Medicare national rate | $576.17 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $576.17 |
HOPD (APC 5165) Hospital outpatient department | $6,048.05 |
ASC (PI A2) Ambulatory surgical center (freestanding) | $3,025.62 |
Common denial reasons
The recurring reasons claims for CPT 21026 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Medical necessity not established — no imaging or failed conservative treatment documented prior to surgery
- Operative note lacks specificity on which facial bone(s) were excised; 'facial area' is insufficient for audit defense
- Procedure billed with a diagnosis code that doesn't support bone excision (e.g., soft-tissue mass codes when bone involvement isn't documented)
- Unbundling of debridement or closure codes that are integral to 21026 without clinically distinct documentation to support separate billing
- Global period violations — post-op E/M visits billed without modifier 24 when they fall within the 90-day window
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01Does 21026 have a global period, and what does it include?
02Can 21026 be billed bilaterally with modifier 50?
03What diagnosis codes most commonly support 21026?
04Is a pathology report required to bill 21026?
05When should modifier 22 be appended to 21026?
06How does the HOPD vs. ASC payment differential affect site-of-service decisions?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/files/document/08-chapter8-ncci-medicare-policy-manual-2026-final.pdf
- 03cgsmedicare.comhttps://www.cgsmedicare.com/medicare_dynamic/j15/partb/ptpb/ptp.aspx
- 04genhealth.aihttps://genhealth.ai/code/cpt4/21026-excision-of-bone-eg-for-osteomyelitis-or-bone-abscess-facial-bones
- 05mdclarity.comhttps://www.mdclarity.com/cpt-code/21026
- 06aapc.comhttps://www.aapc.com/blog/28071-understand-modifier-59-and-ncci-bundling/
Mira AI Scribe
Mira's AI scribe captures the specific facial bone(s) involved by anatomic name, the extent of osseous resection, debridement findings, and prior treatment history directly from dictation. This prevents the most common audit flag for 21026 — operative notes that document a 'facial bone procedure' without specifying which bone was excised or why conservative management was insufficient.
See how Mira captures CPT 21026 documentation